Comparison	comparison	O	O	O	O
of	of	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O

glycopyrrolate	glycopyrrolate	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
prevention	prevention	O	O	O	O
of	of	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
following	following	O	O	O	O
repeated	repeated	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
effectiveness	effectiveness	O	O	O	O
of	of	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
glycopyrrolate	glycopyrrolate	CHEMICALS	O	OTHERS	I
5	5	O	O	O	O
and	and	O	O	O	O
10	10	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
and	and	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
10	10	O	O	O	O
and	and	O	O	O	O
20	20	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O

immediately	immediately	O	O	O	O
before	before	O	O	O	O
the	the	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
,	,	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
following	following	O	O	O	O
repeated	repeated	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
children	children	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
control	control	O	O	O	O
group	group	O	O	O	O
was	was	O	O	O	O
included	included	O	O	O	O
for	for	O	O	O	O
comparison	comparison	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
lower	lower	O	O	O	O
dose	dose	O	O	O	O
range	range	O	O	O	O
of	of	O	O	O	O
glycopyrrolate	glycopyrrolate	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
frequency	frequency	O	O	O	O
of	of	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
of	of	O	O	O	O
50	50	O	O	O	O
%	%	O	O	O	O
was	was	O	O	O	O
noted	noted	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
group	group	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
this	this	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
significantly	significantly	O	O	O	O
different	different	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
frequency	frequency	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
active	active	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

Bradycardia	bradycardia	O	DISEASE	OTHERS	I
(	(	O	O	O	O
defined	defined	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
to	to	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
50	50	O	O	O	O
beat	beat	O	O	O	O
min-1	min-1	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
prevented	prevented	O	O	O	O
when	when	O	O	O	O
the	the	O	O	O	O
larger	larger	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
either	either	O	O	O	O
active	active	O	O	O	O
drug	drug	O	O	O	O
was	was	O	O	O	O
used	used	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
recommended	recommended	O	O	O	O
that	that	O	O	O	O
either	either	O	O	O	O
glycopyrrolate	glycopyrrolate	CHEMICALS	O	OTHERS	I
10	10	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
or	or	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
20	20	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
should	should	O	O	O	O
immediately	immediately	O	O	O	O
precede	precede	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
children	children	O	O	O	O
,	,	O	O	O	O
if	if	O	O	O	O
the	the	O	O	O	O
repeated	repeated	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
anticipated	anticipated	O	O	O	O
.	.	O	O	O	O

